Coronavirus infections in Germany top 1 million, AstraZeneca plans new vaccine trials | DW News
November 27, 2020
75,567
685
325
1.34%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Dw News Episodes Around November 27, 2020
See what was published immediately before and after this episode.
15:12Now PlayingCoronavirus infections in Germany top 1 million, AstraZeneca plans new vaccine trials | DW News
YouTube Description
as posted by the channelGermany passed 1 million cases of coronavirus since the pandemic began, according to figures compiled by the US Johns Hopkins University. The grim milestone was passed after German health authorities recorded 22,268 new cases on Thursday, and 389 deaths. Overall, 15,160 people have died. Germany has extended its partial lockdown into December. Chancellor Angela Merkel has defended the extension of the partial lockdown in a speech to lawmakers. She said the current measures had enjoyed some success, but more was needed to avoid the health system being overwhelmed.
Americans awoke on Thursday to celebrate a Thanksgiving Day like no other, with families urged to avoid gatherings to prevent spreading the coronavirus that has killed more than 260,000 US citizens. The world's largest parade, Macy's Thanksgiving Day Parade in New York City, a mainstay of the festivities, has been scaled down this year, with the millions who typically attend staying home and the procession lasting for one block, rather than two miles (3.2 kilometers). Many families are left resigned to online meetings as they tuck in to their Thanksgiving turkey dinners. But the TSA reported more than 6 million airline passengers passed through US airports between Friday and Wednesday, making it the busiest weekend since mid-March. Medical experts have expressed fears that the holiday season will cause more surges in infections.
UK asks regulator to study AstraZeneca COVID vaccine. The vaccine is said to be on average about 70% effective, but there have been some concerns after controversy emerged surrounding the study. If it is approved, the first doses could be given out by the end of the year. Now AstraZeneca is planning an additional global trial of its COVID-19 vaccine.
For more news go to
Follow DW on social media:
Für Videos in deutscher Sprache besuchen Sie
#Coronavirus #Covid19 #Vaccine
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.